Vetter’s Development Service Doubles its Revenues and Grows its Capabilities
CHICAGO & RAVENSBURG, Germany--(BUSINESS WIRE)--Vetter, a leading contract development and manufacturing organization (CDMO), reports that its Development Service doubled its revenues over the last five years, due to increased customer demand for support on complex biologics. Vetter Development Service (VDS) supports products from preclinical development through Phase III and develops robust processes that enable a seamless transfer to Vetter Commercial Manufacturing. Offering a continuum of service, the global VDS organization comprises more than 150 scientists, engineers and other personnel. Vetter’s Chicago facility provides early-stage clinical production, featuring equipment optimized for small-batch manufacturing. Ravensburg facilities support a range of development products through Phase III and feature sophisticated new technologies with enhanced analytical capabilities.